Early Registration Is Open for #ISLB25! Register by October 10, 2025, to take advantage of discounted rates and secure your spot at the 7th Annual Congress of Liquid Biopsy in Orlando, Florida. Full In-Person Registration Includes: ✅ Access to all Scientific Sessions (except

Today I had the opportunity to present our ePoster on a meta-analysis of pulmonary toxicity in patients affected by lung cancer •4100 pts analyzed •36.1% toxicity •29.9% grade ≥3 events 👉 Stay tuned #WCLC25 #LungCancer IASLC Rodrigo Paredes, MD Christian Rolfo RolfoLab

Part of our Young Committee is also present at #WCLC25 Many exciting abstracts on #liquidbiopsy in #lungcancer 🩸 Stay tuned for our usual post-conference editorial! 📰 Roberto Borea, MD Ana Ortega Franco Diego de Miguel Perez Surbhi Singhal Umberto Malapelle Christian Rolfo David Gandara

Very proud our team at RolfoLab ! Roberto Borea, MD & Rodrigo Paredes, MD presenting our Incidence and Severity of Interstitial Lung Disease Associated With Antibody-Drug Conjugates in NSCLC and SCLC: A Meta-Analysis. #WCLC25 Important topic. Ohio State Medical Oncology The James at Ohio State IASLC

It was so nice to meet you Claudia PARISI, MD See you soon in la Riviera! ☀️ #WCLC25 IASLC academy

Come to room 11 to attend the ongoing workshop on NGS and reporting in NSCLC with great experts in the field prof. Ola Khorshid Christian Rolfo Gianluca Russo #WCLC25 IASLC Umberto Malapelle

Last day at #WCLC25 we are diving in the NGS sequencing results! 🧬 Leading experts discuss how to use NGS to navigate in the rea-world scenario! #molecularpathologist #oncologist Christian Rolfo prof. Ola Khorshid #GianlucaRusso Umberto Malapelle IASLC

#MAP2025: Umberto Malapelle describes how new technologies – #multiomic spatial profiling, #ctDNA analysis and #AI – can be integrated for a deeper understanding of cancer complexity. Read more in the #ESMODailyReporter. 🔗 ow.ly/sLgx50WXqqS

🫁 50 Years in NSCLC care. From limited tools to molecular profiling, CT screening, and expanding therapies, lung cancer care has been transformed. IASLC offers a guide summarizing progress and today’s standards for clinicians. 📖 JTO & JTO CRR DOI 👉 doi.org/10.1016/j.jtho…

A Caserta l’evento “Dal bench alla pratica clinica: l’integrazione molecolare nei test in oncologia”. Un confronto prezioso tra discipline e professioni diverse: solo con un approccio multidisciplinare e integrato possiamo offrire diagnosi più precise e terapie personalizzate.

Submit your abstract for #ISLB25 before 23:59 PST today. Join the conversation. Submit here: 2025.islb.info/call-for-abstr… Christian Rolfo ELO Yüksel Ürün Umberto Malapelle David Gandara M JOSE SERRANO Lab (LB&Cancer Interception group)

Outstanding presentation by Dr. Triparna Sen (Sen-Lab) our associate Director Research at Ohio State Medical Oncology at the Ground Round The James at Ohio State! Congratulations. Honored to call Dr Sen my friend and colleague

✨ Inspiring presentation by Silvia Stacchiotti from Istituto Tumori at The James at Ohio State A great overview of #sarcomas and their ultra-rare subtypes 🔍 Over the past decades, major progress has been made in classification, but much still needs to be done to expand therapeutic options! 💊

So honored to have at The James at Ohio State in our OSU Sarcoma Annual Meeting Dr Silvia Stacchiotti Silvia Stacchiotti President of CTOS . A great clinical researcher and a good friend from my time at Istituto Tumori in Milan. Thanks for your visit! Ohio State Medical Oncology

📍 Milan 2001 📍 Columbus 2025 24 years of friendship and collaboration. Always inspiring to see how two 🌟🌟 minds can make work better! Ohio State’s #Sarcoma Symposium #raretumors #research Christian Rolfo Silvia Stacchiotti Istituto Tumori The James at Ohio State Ohio State Medical Oncology

Amazing panel Tanios Bekaii-Saab, MD Brian Rini, MD Vivek Subbiah, MD Christian Rolfo discussing what’s new in NGS and liquid biopsy,

Prof.David Gandara from UC Davis Health at The James at Ohio State: delivering a world-class report on #liquidbiopsy & #lungcancer. Former IASLC president, and now CMO International Society of Liquid Biopsy A wonderful overview, always inspiring listen to his talk 💡 Christian Rolfo RolfoLab

Honored to present Translational Therapy seminar @OSUCCC on Convergence of Precision Oncology & Liquid Biopsy. Included our recent work on impact of tumor fraction (TF) for concordance of tissue/plasma ctDNA & association with NSCLC survival ( Mack et al. CCR 2025) Lung-MAP

🫁 50 years of #LungCancer: - 2004: #EGFR mutations → targeted therapy era - 2007: #ALK fusions → crizotinib - 2012: First #immunotherapy responses ➡️5-year OS from 2.6% to 13.4% ➡️screening cuts mortality by 20% #PrecisionMedicine IASLC Jarushka Naidoo JTO & JTO CRR

At The James at Ohio State, Dr. Margaret Gatti-Mays and her team are pioneering a bold new approach to treating metastatic breast cancer using modified “natural killer” cells. health.osu.edu/health/cancer/…